
30 mg retatrutide price: what to check before ordering
The 30 mg retatrutide price sits on the product page; the checks that make a research-use-only order verifiable are a named-laboratory certificate for that exact product, the identity and purity it reports, and the shipping window.
The 30 mg retatrutide price appears on the AKH BioLabs Retatrutide listing rather than in this article, and the checks that make an order verifiable are a certificate from a named laboratory outside the seller for that exact product, the identity and purity that report carries, and the shipping details shown on the listing. The Retatrutide 30mg page publishes the fill size, the formula, the certificate fields and the shipping window; the sections below set out how each of those is checked, on that listing or on any other.
The scope is deliberately narrow. This article is written for laboratory buyers comparing research-use-only listings of the 30mg presentation; it quotes no price, offers no guidance on human use, and keeps the compound literature as a separate question that belongs to the retatrutide research record. What follows is about documents, and about which of them a buyer can read before paying.
Key takeaways
- The 30mg figure is the stated fill of the lyophilised powder; the purity figure is a separate measurement taken by a laboratory.
- A certificate is checkable only when it names the product, the batch, the test date, the laboratory and the result.
- The AKH BioLabs Retatrutide page publishes batch 26138, tested 10 Aug 2026 by the Brown Institute of Biomolecular Research, at a stated purity of 99.86%.
- The research record states that retatrutide was not an approved medicine in any jurisdiction as of August 2026.
What the 30 mg retatrutide price covers, and what it does not
The listing describes Retatrutide as 30mg lyophilised powder for in-vitro and laboratory research, states a purity of 99.86% and gives the formula as C112H164N26O31. The results line on the certificate published with that page reads RT: 30mg | Purity: 99.86%, so the 30mg figure is the stated fill for that batch and the percentage is a distinct measurement produced by the laboratory. The two numbers sit side by side on the same line and they do not convert into one another.
The price belongs to a third category. A listing price reflects the presentation offered, the currency the shop displays and the commercial terms at the moment of reading. It does not describe a batch, and it cannot be matched against a laboratory report. That is the reason this article directs the reader to the product page for the figure and gives its space to fields that can be verified instead.
The COA archive states plainly that how to read the numbers, and what they cannot establish, is covered in the certificate guide and the lab glossary. A buyer who wants to understand the difference between a chromatographic result and a quantity of material has a route to that explanation without relying on a shop's marketing copy.
Four checks that apply to any seller
A seller can publish a certificate that looks complete and still leave the reader unable to check it. The difference can sit in the certificate and the shipping fields, both of which are published on a public page.
The certificate and shipping details do not depend on a private reply. That matters, because a check that requires contacting the shop cannot be reproduced by the next reader and leaves no record to return to if the material on arrival does not match.
- 01
A certificate for that exact product
The report should cover the compound and the presentation being ordered, not a neighbouring product line. The AKH archive records one row per Certificate: one batch, tested once, by a named laboratory outside the seller, on a report ordered by the manufacturer.
- 02
The identity and purity the report states
The results line should name the compound and the fill, then give the measurement. For the Retatrutide listing that line reads RT: 30mg | Purity: 99.86%, and the laboratory named beside it is the Brown Institute of Biomolecular Research.
- 03
Shipping to the destination country
A listing should state where it ships and how long delivery takes rather than leaving the question open. The Retatrutide page states worldwide delivery within a 9-14 day window.
Reading the Retatrutide certificate: batch 26138
The Retatrutide page carries one Certificate, described there as published unaltered: a test report from a named laboratory outside AKH, ordered by the manufacturer and shown exactly as the laboratory issued it, with a printed copy in every parcel. The fields beside it are specific rather than generic.
Batch 26138, test date 10 Aug 2026, task ID #1812434, purity 99.86%, results RT: 30mg | Purity: 99.86%, laboratory Brown Institute of Biomolecular Research. The same batch occupies one row in the COA archive, with the same product name, the same batch number, the same purity, the same test date and the same laboratory. Matching those two views is what ties a document to a specific batch rather than to a product line.
What the certificate settles is narrow and worth stating plainly. It identifies which batch the report covers, which laboratory produced the measurement, and what the results line says. It does not settle regulatory status, and it does not indicate whether the material suits any particular study design.
Why a reta price search should settle regulatory status first
The product listing notes that retatrutide is often searched as GLP-3 or reta. Retatrutide, development code LY3437943, is described in the research record as an investigational single-peptide triple agonist of the GIP, GLP-1 and glucagon receptors. The same record states that as of August 2026 the compound was not an approved medicine in any jurisdiction.
The clinical record behind that statement is real and still growing. A 2023 phase 2 trial was a double-blind, randomised, placebo-controlled study involving 338 adults with a body-mass index of 30 or higher, or 27 to less than 30 alongside at least one weight-related condition, over 48 weeks; the abstract names Eli Lilly as funder and NCT04881760 as the registration number. Design papers for the phase 3 TRIUMPH programme followed, and the research record notes that the first phase 3 readout appeared in The Lancet in 2026.
A research-use-only listing sits outside that clinical programme. The catalogue entry supplies the material for laboratory work and states that it is not for human or veterinary use, and a batch certificate documents measurement rather than approval. That distinction rests on the stated research-use-only status and on what the batch certificate documents.
Before ordering: where each check sits on the Retatrutide page
Once the documents line up, the order itself is the simple part. The Retatrutide 30mg listing sets out the 30mg presentation, the stated purity, the formula, the named-laboratory certificate for batch 26138, a product FAQ covering storage, testing and intended use, and a worldwide shipping window of 9-14 days, with the price displayed on that page rather than here. The archive at /lab/coa is where the same batch row can be confirmed afterwards.
Two checks remain after delivery, and both are quick. The batch number on the container is compared with batch 26138 on the published report, and the report is re-read for the laboratory name and the test date rather than for the percentage alone. If the batch differs, the document describes other material, whatever the purity figure says.
The compound questions behind the purchase are not answered by any of this. Study design, reported findings and the limits of the published work are collected in the research record, which is kept separate from the buying checks on purpose: one is a matter of documents, the other is a matter of evidence.
Common questions.
- What is included in the 30 mg retatrutide price?
The listing prices the 30mg presentation of the lyophilised powder, and the figure itself is displayed on the product page. The 30mg is the stated fill for the batch, recorded in the results line as RT: 30mg | Purity: 99.86%, and it sits beside a separate purity measurement rather than describing the same quantity. The page also publishes the formula, the named laboratory, the batch number, the test date and the shipping window.
- Does a higher retatrutide 30mg price indicate a better batch?
No checkable link exists between price and batch quality. A price reflects the presentation offered and the seller's commercial terms. The batch facts that can be verified are the certificate fields: product, batch number, test date, laboratory and result. For the AKH listing those read batch 26138, tested 10 Aug 2026 by the Brown Institute of Biomolecular Research, with a stated purity of 99.86%.
- Which fields make a retatrutide certificate checkable?
Five fields do most of the work: the compound and fill named on the report, the batch number, the test date, the laboratory that issued the measurement, and the results line. A document missing the batch or the laboratory cannot be tied to a container. The archive describes each row as one Certificate, one batch, tested once, by a named laboratory outside AKH.
- Does buying retatrutide for research imply any approval status?
No. The research record states that as of August 2026 retatrutide was not an approved medicine in any jurisdiction, and the catalogue entry supplies 30mg lyophilised powder for laboratory research with a statement that it is not for human or veterinary use. A batch certificate from a named laboratory outside AKH documents a measurement for that batch and does not change the compound's regulatory position.